HGI Capital Management’s Pfizer PFE Stock Holding History

HGI Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-9,667	Closed	-$337K	–	66
2020 Q3	$337K	Sell	9,667 -873	-8%	-$30.6K	0.2%	52
2020 Q2	$327K	Hold	10,540	–	–	0.2%	45
2020 Q1	$326K	Hold	10,540	–	–	0.31%	41
2019 Q4	$392K	Hold	10,540	–	–	0.19%	52
2019 Q3	$359K	Hold	10,540	–	–	0.2%	51
2019 Q2	$433K	Sell	10,540 -10,540	-50%	-$419K	0.2%	59
2019 Q1	$849K	Hold	21,080	–	–	0.45%	46
2018 Q4	$873K	Hold	21,080	–	–	0.75%	32
2018 Q3	$881K	Sell	21,080 -2,878	-12%	-$111K	0.61%	33
2018 Q2	$825K	Buy	+23,958	New	+$819K	0.35%	49

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HGI Capital Management's PFE Position: Q4 2020 in Review

HGI Capital Management sold out of Pfizer (PFE) in Q4 2020, closing a stake of 9,667 shares — an estimated $337K sold.

HGI Capital Management first reported a position in PFE in Q2 2018 and held it in 10 quarters. The position peaked at $881K in Q3 2018. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

HGI Capital Management reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
HGI Capital Management sold 9,667 Pfizer shares in Q4 2020, an estimated $337K.
HGI Capital Management first reported a position in Pfizer in Q2 2018 and held it in 10 quarters.
HGI Capital Management's Pfizer position peaked at $881K in Q3 2018.
2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on HGI Capital Management's 13F filing for Q4 2020, filed 4 Feb 2021.